560 news items
Page 28 of 28
eenblv7fcvfv2 v31ow
4 Apr 24
. Cancer Tissue Diagnostic Market Demand: The cancer tissue
yr9z1dv0babgfr4i1pj2dl44sn
CVAC
4 Apr 24
the areas of prophylactic vaccines, cancer therapies, antibody therapies, and the treatment of rare diseases. CureVac N.V. has its headquarters
sbsrnfxr
MRK
4 Apr 24
with metastatic non-small cell lung cancer (NSCLC) whose tumors harbor KRAS G12C mutations and express PD-L1 (tumor
i6qwri773wris6fqb2pmbnxmwsxqcwih35w06kr
ACHL
4 Apr 24
will inform the development of cNeT and related neoantigen vaccine and TCR-T therapies," said Dr Iraj Ali, Chief Executive Officer of Achilles
q8gpyfdjz2bjnvb88mhyg16othet4f gx
ACHL
4 Apr 24
cell lung cancer (NSCLC) and the THETIS study in recurrent or metastatic malignant melanoma. The update includes data from 18 patients across CHIRON
2tw0k3zp6qtxsgo859 eb4cgr4rhyizha3rvnw
MRK
3 Apr 24
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer
ajdj7gw ddg15yubytgtz1oecfgphiz9sdnbtoqbafrdsx
3 Apr 24
viral hepatitis, a major risk factor for liver cancer, through vaccination programs, awareness campaigns, and improved access to antiviral treatments
h6xy1mzwmcp1vpxq6mkrsvwmwofw i4u4ze0v
KTRA
3 Apr 24
Biosciences.
The combined company will focus on advancing TuHURA’s personalized cancer vaccines and bi-functional ADCS. These two
xgtrnj0557usftdiyleo 3u3f
PESI
3 Apr 24
puberty, bone variations, or behavioral changes; increased risk of prostate, kidney, and testicular cancers; reduced ability of the body's immune system
w8oc6hvmw
3 Apr 24
and aggressiveness of tumors, and both are recognized as important targets for cancer vaccines and therapeutics
fjoh0i2
VBIV
3 Apr 24
tumor response data from the ongoing Phase 2b study of VBI-1901, VBI's cancer vaccine immunotherapeutic candidate, in recurrent glioblastoma (rGBM
u9wn6arti ri124m30723l13
YS
3 Apr 24
, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced the full
mm1hyv06hg3ygbny4mnxkkjixqbfv0p7
SNGX
3 Apr 24
.
"In treating CTCL, which is a chronic cancer with no cure, long-term safety is a strong driver of treatment choice. Most current
1k5pqmcvmfigllrz885ka8dey69ox3yq3 znud
KTRA
3 Apr 24
TuHURA is planning to advance a single Phase 3 trial for IFx-2.0 personalized cancer vaccine as adjunctive therapy with Keytruda®
oxg4 vv22zrf18p2
KTRA
3 Apr 24
for IFx-2.0 personalized cancer vaccine as adjunctive therapy with Keytruda® in first-line therapy for advanced Merkel cell carcinoma in 2H 2024
iw6bn aup9zo
3 Apr 24
NEWSWIRE) -- CancerVax, Inc., developer of a breakthrough Universal Cancer Vaccine treatment that will use the body's immune system to fight cancer, today
m02pr9jjd379o3 j0c1h4rx0i0bdkhvig50l
2 Apr 24
and the rollout of vaccination campaigns, healthcare services, including hereditary cancer testing, gradually resumed normal operations. Health systems
r5lgrvhjv91u4zx9c463sf1wrdizsh80qhm3ho2fokcz122na
MVST
2 Apr 24
: What’s Going On With Small Cap Cancer Vaccine Focused Gritstone Bio Stock On Tuesday?
MVST Price Action
rerwbdg27bcf1v1yz009ba0gs3xyo6752nkvtat
GRTS
2 Apr 24
) released preliminary data from the ongoing, signal-seeking Phase 2 portion of the Phase 2/3 study evaluating GRANITE, its personalized neoantigen cancer
kviq95pbxpwm0m3bmqi05p8
MRNA
MYNZ
PFE
2 Apr 24
an entirely new growth era.
Revolutionizing cancer treatment seems to be one of the themes of 2024.
Moderna’s vaccine